GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY

被引:0
|
作者
Sever, M. Jensterle [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
230
引用
收藏
页码:A6 / A6
页数:1
相关论文
共 50 条
  • [1] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [2] GLP-1 and Amylin in the Treatment of Obesity
    T. Jorsal
    J. Rungby
    F. K. Knop
    T. Vilsbøll
    Current Diabetes Reports, 2016, 16
  • [3] GLP-1 and Amylin in the Treatment of Obesity
    Jorsal, T.
    Rungby, J.
    Knop, F. K.
    Vilsboll, T.
    CURRENT DIABETES REPORTS, 2016, 16 (01) : 1 - 7
  • [4] Obesity and GLP-1
    De Oca, Alejandra Perez-Montes
    Pellitero, Silvia
    Puig-Domingo, Manel
    MINERVA ENDOCRINOLOGY, 2021, 46 (02): : 168 - 176
  • [5] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [6] GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy
    Lafferty, Ryan. A. A.
    Flatt, Peter. R. R.
    Irwin, Nigel
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (05) : 587 - 597
  • [7] Combining GLP-1 and glucagon for the treatment of obesity and diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 481 - 482
  • [8] GLP-1 Agonists for Obesity
    Langland, James T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [9] GLP-1 Agonists for Obesity
    Kurian, Marina
    Rogers, Ann M.
    Peterson, Richard M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [10] GLP-1 Agonists for Obesity
    Dellgren, Johan
    Emanuel, Ezekiel J.
    Persad, Govind
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,